Breast cancer is the most common cancer and the second most frequent cause of cancer mortality in women in the United States (1, 2). Exercise reduces the risk of breast cancer. Therefore, moderate physical activity or exercise is important in breast cancer risk reduction (3). Cytochrome P450 (CYP450) enzymes are hemecontaining proteins that mediate drug biotransformation (4). CYP450 enzymes perform Phase I metabolism of xenobiotic drugs and toxins. There is a relationship between CYP450 and breast cancer (5), but there have been fewer studies of CYP450 and exercise in this disease. Therefore, the purpose of this study was to determine whether breast cancer is differentially affected by CYP450 and exercise could play an important role in breast cancer reduced and CYP450 enzymes within this liver. Fifteen female BALB/C nude mice (10 wk old) in Chungju-si in 2014 were randomly divided into control (n=5), exercise (n=5, 18 m/min treadmill for 30 min, 5 d/wk for 12 wk), and drug treatment (n=5, Taxol 16 mg/kg, 5 d/wk for 12 wk) groups. This study was approved by the local university and all rules by Helsinki declaration were observed exactly. The MCF-7 human breast adenocarcinoma cell line was used as a model of human breast cancer (ATCC; NIH: MCF-7, Catalog #HTB-22). Cells were maintained in RPMI-1640 supplemented with 10% FBS at 37 °C in 5% CO2. Cells were collected and suspended at 25 × 10 6 cells/mL in a mixture of Matrigel (BD Biosciences; Chicago, IL: Lot #005002, 14.6 mg/mL). Mice were injected with 0.2 mL of the cell suspension for a final dose of 5 × 10 6 cells. The cell suspensions were injected subcutaneously on the ventral side of the abdomen using a 23-gauge needle. Beginning approximately 14 d post-implantation, palpable tumors were measured with electronic calipers (Fowler Instruments; Newton, MA) across two perpendicular dimensions. Mice were randomly sorted into groups of three, based on tumor volume. Livers were obtained, weighed, homogenized in 0.1 M potassium phosphate buffer, PH 7.4, containing 0.125 M potassium chloride, 1.0 mM EDTA, and a protease inhibitor mixture (Sigma), and centrifuged at 13000 gr for 25 min. The postmitochondrial fraction was ultra-centrifuged for 45 min at 250000 gr to obtain microsomes. The pellets were suspended in 10 mM Tris-acetate buffer, pH 7.4, containing 0.1 mM EDTA and 23% glycerol and stored at -80 °C. Protein concentrations were measured using the bicinchoninic acid (BCA) protein assay kit (ThermoFisher Scientific, Rockport, IL) with bovine serum albumin.
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